Now celebrating its 19th meeting, BioEquity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. BioEquity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. Delegates from 24 nations attended BioEquity Europe last year in Paris.
LISAvienna will be available at BioEquity Europe 2018. Please contact Jürgen Fuchs for details and if you would like to join in or to arrange a meeting in Ghent.